Open Save New
FeedNavigator / National Library of Health Sciences
 
  
Tutkijat / Oulu
AddAla-Kokko, L.
AddAla-Kokko, T(ero)
AddAla-Korpela, M(ika)
AddAlahuhta, S.
AddAlén, M(arkku)
AddAntikainen, R.
AddAnttonen, V(uokko)
AddBiancari, F(austo)
AddBloigu, R(isto)
AddEskelinen, S.
AddFlinkkilä, T(apio)
AddHakkola, J.
AddHallman, M.
AddHartikainen, A(nna)-L(iisa)
AddHausen, H.
AddHautala, N(ina)
AddHautala, T(imo)
AddHeape, A.
AddHerzig, K(arl)-H(einz)
AddHillbom, M.
AddHiltunen, J.K.
AddHörkko, S.
AddHuikuri, H(eikki)
AddHukkanen J(anne)
AddIgnatius, J.
AddIsohanni, M.
AddJaakkola, J.
AddJaakkola, M(aritta) S.
AddJaakola, V-P.
AddJämsä, T(imo)
AddJanhonen, S.
AddJartti, T(uomas)
AddJärvelin, M(arjo)-R(iitta)
AddJokelainen, J(ari)
AddJuffer, A(ndré) H.
AddJunttila, J(uhani)
AddJuvonen, T.
AddKaarteenaho, R(iitta)
AddKajantie, E(ero)*(THL/OY)
AddKarppinen (Koivunen), P(eppi)
AddKarppinen, J(aro)
AddKarttunen, T.J.
AddKeinänen-Kiukaanniemi, S(irkka)
AddKerkelä, R(isto)
AddKesäniemi, Y(rjö) A(ntero)
AddKettunen, J(ohannes)
AddKietzmann, T(homas).
AddKivirikko, K.I.
AddKnuuttila, M.
AddKoivukangas, J.
AddKursula, P(etri)
AddKyngäs, H.
AddLarivaara, P.
AddLarmas, M.
AddLehenkari, P(etri)
AddLehtiö, L(ari)
AddLeppilahti, J.
AddLuukinen, H.
AddMainio A
AddMajamaa, K.
AddMäki, P(irjo)
AddMäkikallio, T(imo) H.
AddMännikkö, M(inna)
AddManninen, A(ki).
AddMartikainen, H(annu)
AddMiettunen, J(ouko)
AddMyllyharju, J(ohanna)
AddMyllylä, R.
AddMyllylä, V.
AddNäyhä, S(imo)
AddNeubauer, P.
AddNieminen, M(iika) T.
AddNieminen, P(entti)
AddNiinimäki, J(aakko)
AddOhukainen, P(auli)
AddOikarinen, A.
AddOikarinen, K.
AddPelkonen, O(lavi)
AddPetäjä-Repo, U.E.
AddPihlajaniemi, T(aina)
AddPirttiniemi, P(ertti)
AddPuistola, U(lla)
AddRajaniemi, H.J.
AddRäsänen, P.
AddRaustia, A.
AddRemes, A(nne)
AddRisteli, J.
AddRistiniemi, J.
AddRuddock, L.W.
AddRuokonen, A.
AddRyynänen, M.
AddSaarakkala, S.
AddSaari, A.
AddSalo, T(uula)
AddSándor, G(eorge) K.
AddSavolainen, E-R.
AddSavolainen, M.J.
AddSavolainen, O.
AddSillanpää, M(ikko).
AddSoininen, R.
AddSorri, M.
AddTaanila, A.
AddTapiainen, T(erhi)
AddTervonen, O(smo)
AddTimonen, M(arkku)
AddTurpeenniemi-Hujanen, T.
AddTuukkanen, J(uha)
AddTuulonen, A.
AddUhari, M.
AddUkkola, O(lavi)
AddUusimaa, J.
AddVainio, O.
AddVainio, S.
AddVäyrynen, J(uha) P.
AddVeijola, J(uha)
AddVeijola, R(iitta)
AddVirokannas, H.
AddVoipio, H(anna)-M(arja)
AddVuolteenaho, O.
AddWeckström, M.
AddWei, GH.
AddWierenga, R.K.
AddWinqvist, R(obert)
AddYlänne, J.
AddYlitalo, K(ari)

Scholar Chart >>



»My Articles

»Latest Feeds

»Popular Feeds
Search Feed Catalog by Name:
Immunohistochemical Study of Matrix Metalloproteinase 9 and Tissue Inhibitor of Matrix Metalloproteinase 1 in Benign and Malignant Breast Tissue - Strong Expression in Intraductal Carcinomas of the Breast.Turpeenniemi-Hujanen, T.4406 dayssaveRefWorks
Fluorouracil, Epirubicin, and Cyclophosphamide With Either Docetaxel or Vinorelbine, With or Without Trastuzumab, As Adjuvant Treatments of Breast Cancer: Final Results of the FinHer Trial.Turpeenniemi-Hujanen, T.4408 dayssaveRefWorks
Docetaxel versus docetaxel alternating with gemcitabine as treatments of advanced breast cancer: final analysis of a randomised trial.Turpeenniemi-Hujanen, T.4430 dayssaveRefWorks
Lack of prognostic value of MMP-9 expression and immunohistochemically defined germinal center phenotype in patients with diffuse large B-cell lymphoma treated with modern chemotherapy with or without CD20 antibody.Turpeenniemi-Hujanen, T.4434 dayssaveRefWorks
Docetaxel 100 versus 80 mg/m2 as adjuvant treatments of early breast cancer: an exploratory analysis of a randomised trial.Turpeenniemi-Hujanen, T.4695 dayssaveRefWorks
High serum TIMP-1 is associated with adverse prognosis in endometrial carcinoma.Turpeenniemi-Hujanen, T.4749 dayssaveRefWorks
Low Circulating Levels of ProMMP-2 Are Associated with Adverse Prognosis in Bladder Cancer.Turpeenniemi-Hujanen, T.4818 dayssaveRefWorks
Matrix metalloproteinase-9 (MMP-9) immunoreactive protein in urinary bladder cancer: a marker of favorable prognosis.Turpeenniemi-Hujanen, T.4882 dayssaveRefWorks
Prognostic significance of p53 and MMP-9 expression in follicular lymphoma.Turpeenniemi-Hujanen, T.4888 dayssaveRefWorks
Molecular subtypes of breast cancers detected in mammography screening and outside of screening.Turpeenniemi-Hujanen, T.4897 dayssaveRefWorks
High preoperative plasma TIMP-1 is prognostic for early relapse in primary breast carcinoma.Turpeenniemi-Hujanen, T.4932 dayssaveRefWorks
Comparison of the prognostic value of matrix metalloproteinases 2 and 9 in cutaneous melanoma.Turpeenniemi-Hujanen, T.5070 dayssaveRefWorks
High serum TIMP-1 correlates with poor prognosis in breast carcinoma - A validation study.Turpeenniemi-Hujanen, T.5112 dayssaveRefWorks
Plasma MMP-2-TIMP-2 complex levels measured during follow-up predict a risk of relapse in patients with malignant lymphoma.Turpeenniemi-Hujanen, T.5121 dayssaveRefWorks
Prognostic Significance of Extracellular Matrix Metalloproteinase Inducer and Matrix Metalloproteinase 2 in Epithelial Ovarian Cancer.Turpeenniemi-Hujanen, T.5147 dayssaveRefWorks
Matrix metalloproteinase-2 (MMP-2) and -9 (MMP-9) and their tissue inhibitors (TIMP-1 and TIMP-2) in differential diagnosis between low malignant potential (LMP) and malignant ovarian tumours.Turpeenniemi-Hujanen, T.5216 dayssaveRefWorks
Serum tissue inhibitor of metalloproteinase-2 (TIMP-2) and matrix metalloproteinase-2 in complex with the inhibitor (MMP-2:TIMP-2) as prognostic markers in bladder cancer.Turpeenniemi-Hujanen, T.5366 dayssaveRefWorks
The value of sequential serum measurements of gelatinases and tissue inhibitors during chemotherapy in ovarian cancer.Turpeenniemi-Hujanen, T.5435 dayssaveRefWorks
Prognostic significance of matrix metalloproteinase-9 (MMP-9) in epithelial ovarian cancer.Turpeenniemi-Hujanen, T.5526 dayssaveRefWorks
Generalisability of survival estimates for patients with breast cancer - A comparison across two population-based series.Turpeenniemi-Hujanen, T.5535 dayssaveRefWorks
MMP-2 expression associates with CA 125 and clinical course in endometrial carcinoma.Turpeenniemi-Hujanen, T.5543 dayssaveRefWorks
Reply to the letter to the editor from jung.Turpeenniemi-Hujanen, T.5554 dayssaveRefWorks
Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer.Turpeenniemi-Hujanen, T.5554 dayssaveRefWorks
Low serum level of pro-matrix metalloproteinase 2 correlates with aggressive behavior in breast carcinoma.Turpeenniemi-Hujanen, T.5564 dayssaveRefWorks
The effects of impact and non-impact exercise on circulating markers of collagen remodelling in humans.Turpeenniemi-Hujanen, T.5627 dayssaveRefWorks
Matrix metalloproteinases-2 and -9 in cervical cancer: different roles in tumor progression.Turpeenniemi-Hujanen, T.5632 dayssaveRefWorks
 XML / RSS feed
report
 « prev   page 2